Neuraxis Inc (NRXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Sales | 896 | 761 | 667 | 612 | 647 |
| Cost of Goods | 140 | 116 | 97 | 74 | 75 |
| Gross Profit | 756 | 645 | 570 | 538 | 572 |
| Operating Expenses | 3,191 | 2,228 | 2,318 | 2,818 | 2,479 |
| Operating Income | -2,295 | -1,467 | -1,651 | -2,207 | -1,832 |
| Interest Expense | 2 | 2 | 65 | 81 | 257 |
| Other Income | 19 | 21 | -39 | -630 | -31 |
| Pre-tax Income | -2,279 | -1,448 | -1,755 | -2,918 | -2,121 |
| Net Income Continuous | -2,279 | -1,448 | -1,755 | -2,918 | -2,121 |
| Net Income | $-2,279 | $-1,448 | $-1,755 | $-2,918 | $-2,121 |
| EPS Basic Total Ops | -0.33 | -0.23 | -0.25 | -0.42 | -0.32 |
| EPS Basic Continuous Ops | -0.31 | -0.20 | -0.24 | -0.42 | -0.32 |
| EPS Diluted Total Ops | -0.33 | -0.23 | -0.25 | -0.42 | -0.32 |
| EPS Diluted Continuous Ops | -0.31 | -0.20 | -0.24 | -0.42 | -0.32 |
| EPS Diluted Before Non-Recurring Items | -0.31 | -0.21 | -0.25 | -0.42 | N/A |
| EBITDA(a) | $-2,289 | $-1,460 | $-1,601 | $-2,132 | $-1,800 |